The international PROGRESS registry of patients with severe sepsis: drotrecogin alfa (activated) use and patient outcomes

INTRODUCTION: Since the launch of drotrecogin alfa activated (DrotAA), institutions and individual countries have published data on its use in clinical practice, based on audit or registry data. These studies were limited in size and geographic locale and included patients with greater disease sever...

Descripción completa

Detalles Bibliográficos
Autores principales: Martin, Greg, Brunkhorst, Frank M, Janes, Jonathan M, Reinhart, Konrad, Sundin, David P, Garnett, Kassandra, Beale, Richard
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2009
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2717475/
https://www.ncbi.nlm.nih.gov/pubmed/19566927
http://dx.doi.org/10.1186/cc7936

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2717475/
https://www.ncbi.nlm.nih.gov/pubmed/19566927
http://dx.doi.org/10.1186/cc7936

Ejemplares similares